PharmaBlock Sciences News

Yakishi Technology: An indicative announcement that Yakushi\'s debt conversion may trigger a downward revision of the share conversion price conditions

Sep 13 03:42 ET

Pharmaceutical Stone Technology: Huatai United Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Nanjing Yakshi Technology Co., Ltd.

Sep 4 03:58 ET

Yakushi Technology: Announcement on Controlling Shareholders and Actual Controllers Increasing the Company\'s Shares

Aug 26 07:22 ET

PharmaBlock Sciences: Investor Relations Management Information for Pharma Block Sciences on August 19, 2024 (2)

Aug 19 08:24 ET

PharmaBlock Sciences: Investor Relations Management Information for Pharma Block Sciences on August 19, 2024 (1).

Aug 19 08:24 ET

Pharma Block Sciences: Summary of Half-Year Report in 2024.

Aug 16 12:00 ET

Pharma Block Sciences: Pharma block sciences' summary table of non-operational fund usage and other related fund transactions for the first half of 2024.

Aug 16 12:00 ET

Pharma Block Sciences: pharma block sciences public opinion management system

Aug 16 12:00 ET

Pharma Block Sciences: Announcement of the Supervisory Board's resolution.

Aug 16 12:00 ET

Pharma Block Sciences: Half-year report for the year 2024.

Aug 16 12:00 ET

Pharma Block Sciences: Special report on the use of funds raised in the first half of 2024_clean.

Aug 16 12:00 ET

Pharma Block Sciences: Announcement on Increasing the Implementation Sites and Extension of Certain Investment Projects using Raised Funds_clean

Aug 16 12:00 ET

Pharma Block Sciences: Verification opinion by Haitong United Securities Co., Ltd. regarding the addition of implementation locations and extension of part of the funding investment projects of Nanjing Pharma Block Sciences Co., Ltd.

Aug 16 12:00 ET

Pharma Block Sciences: Announcement on the provision for asset impairment in the first half of 2024.

Aug 16 12:00 ET

Pharma Block Sciences: Board of directors resolution announcement.

Aug 16 12:00 ET

Pharma Block Sciences: Announcement on Share Pledges and Pledge Releases by Major Shareholders and Controlling Shareholders.

Jul 16 06:04 ET

Pharma Block Sciences: Announcement on adjusting the grant price of 2022 restricted stock incentive plan.

Jul 2 04:22 ET

Pharma Block Sciences: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.

Jul 2 04:22 ET

Pharma Block Sciences: Announcement on the Appointment of Executive Vice President of the Company.

Jul 2 04:22 ET

Pharma Block Sciences: Announcement of the resolution of the 19th meeting of the third supervisory board.

Jul 2 04:22 ET